To Demonstrate the Non-inferiority of Eyestil Protection® Compared to Vismed® in Terms of Clinical Performance

NCT03803722 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
21
Enrollment
INDUSTRY
Sponsor class

Stopped Slow enrolment process and COVID situation worsened the situation. SIFI has developed a new product with probably a better performance. SIFI changed its marketing strategy and decided that Eyestil® Protection will be not marketed anymore

Conditions

Interventions

Sponsor

SIFI SpA